Jeffrey Rosen

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults

C. Acosta, A. Pedley, James T Peterson, 2019, Human vaccines & immunotherapeutics.

A prospective, multi-centre US clinical trial to determine accuracy of FebriDx point-of-care testing for acute upper respiratory infections with and without a confirmed fever

W. Self, N. Shapiro, M. Filbin, 2018, Annals of medicine.

Immunogenicity and safety of MF59-adjuvanted quadrivalent influenza vaccine versus standard and alternate B strain MF59-adjuvanted trivalent influenza vaccines in older adults.

I. Smolenov, Bin Zhang, Carlos Fierro, 2020, Vaccine.

Comparison of In Vitro Cell Culture and a Mouse Assay for Measuring Infectivity of Cryptosporidium parvum

P. Rochelle, M. M. Marshall, J. Mead, 2002 .

Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine

M. Einstein, M. Levin, G. Dubin, 2011, Human vaccines.

Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18–45 years

M. Einstein, M. Levin, P. Moris, 2011, Human vaccines.

Diagnostic Accuracy of FebriDx: A Rapid Test to Detect Immune Responses to Viral and Bacterial Upper Respiratory Infections

W. Self, N. Shapiro, M. Filbin, 2017, Journal of clinical medicine.

A prospective, multi-centre US clinical trial to determine accuracy of FebriDx point-of-care testing for acute upper respiratory infections with and without a confirmed fever

W. Self, N. Shapiro, M. Filbin, 2018, Annals of medicine.